Mergers & Acquisitions

Amazon to acquire PillPack
The acquisition of Boston-based PillPack is the latest effort from Amazon to make headway in the pharmacy world. The company had previously begun acquiring wholesale licenses in various states.
PMI, Parallax collaborate to focus on alternative nicotine-delivery platforms
Philip Morris International announced on Thursday a strategic collaboration with Canadian-based start-up Parallax to focus on advancing the development and commercialization of a nicotine-delivery system that leverages the advanced technologies in pulmonary medicine.

Walgreens Boots Alliance sees lift in Q3 earnings

Walgreens Boots Alliance on Thursday reported a jump in third quarter earnings and unveiled a $10 billion share repurchase program, which executive vice chairman and CEO Stefano Pessina said demonstrates the retailer’s “confidence in future business performance.”
EnsembleIQ acquires media brands from Lebhar-Friedman

EnsembleIQ announced Thursday that it purchased substantially all of the media, digital and event assets from New York City-based Lebhar-Friedman, including Drug Store News, Chain Store Age and Hardware and Building Supply Dealer.
Lupin, Mylan partner on global Enbrel biosimilar

The two companies will work together to commercialize Lupin’s biosimilar of Enbrel (etanercept), which it has already submitted for European Medicines Agency for approval.
Analysis: Amazon's PillPack acquisition could rattle pharmacy market

Neil Saunders takes a look at how Amazon's recent acquisition of PillPack could affect the pharmacy space.
Rite Aid reports Q1 results

For the first quarter of fiscal year 2019, Rite Aid brought in income of $214.4 million and swung to a net loss of $41.7 million from continuing operations.
McKesson Ventures continues support of portfolio companies with $10K donation

McKesson’s venture capital arm has donated $10,000 to Meals on Wheels America on behalf of its former portfolio company Landmark Health, a provider of in-home, risk-based medical care.
Amneal, Actavis settle generic Rytary litigation

Under the settlement, Ameal will grant Actavis a license to sell its generic Rytary on July 31, 2025, or earlier under certain circumstances.
West-Ward rebranded as Hikma Pharmaceuticals USA

West-Ward Pharmaceuticals has a new name as part of rebranding efforts by its parent company, London-based Hikma Pharmaceuticals.

Amazon to acquire PillPack

PMI, Parallax collaborate to focus on alternative nicotine-delivery platforms

Walgreens Boots Alliance sees lift in Q3 earnings

EnsembleIQ acquires media brands from Lebhar-Friedman

Lupin, Mylan partner on global Enbrel biosimilar

Analysis: Amazon's PillPack acquisition could rattle pharmacy market

Rite Aid reports Q1 results

McKesson Ventures continues support of portfolio companies with $10K donation

Amneal, Actavis settle generic Rytary litigation

West-Ward rebranded as Hikma Pharmaceuticals USA